Serum levels and pharmacodynamics of methotrexate and its metabolite 7-hydroxy methotrexate in Japanese patients with rheumatoid arthritis treated with 2-mg capsule of methotrexate three times per week

Modern Rheumatology

Volumn 15, Issue 6, 2005, Pages 405-409

  Shiozawa, Kazuko ^a   Tanaka, Yasushi ^a   Yoshihara, Ryosuke ^a   Imura, Shigeaki ^a   Murata, Miki ^a   Yamane, Takashi ^b   Miura, Yasushi ^b   Hashiramoto, Akira ^b   Shiozawa, Shunichi ^b  

^a Konan Kakogawa Hospital   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Methotrexate (MTX); Pharmacodynamics; Rheumatoid arthritis (RA); Serum concentration

Indexed keywords

7 HYDROXYMETHOTREXATE; C REACTIVE PROTEIN; METHOTREXATE; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; GRIP STRENGTH; HUMAN; JAPAN; MALE; MORNING STIFFNESS; OUTPATIENT; PHARMACODYNAMICS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 31144440888     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-005-0434-6     Document Type: Article

References (16)

1. American College of Rheumatology Subcommittee on rheumatoid arthritis guidelines: Guidelines for the management of rheumatoid arthritis 2002 update. Arthritis Rheum 2002;46:328-46
2. Y. Suzuki 2002; Methotrexate for the treatment of rheumatoid arthritis in Japan - much more still remains to be resolved (in Japanese). Nippon Rinsho 60:2331-8.12510358
3. HK, Choi MA, Hernan JD, Seeger JM, Robins F, Wolfe 2002; Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study. Lancet 359:1173-7. 10.1016/S0140-6736(02)08213-2 11955534 1:CAS:528:DC%2BD38XivVShsrw%3D 000174846300006
4. ME, Weinblatt AL, Maier PA, Fraser JS, Coblyn 1998; Long-term prospective study of methotrexate in rheumatoid arthritis: Conclusion after 132 months of therapy. J Rheumatol 25:238-42. 9489813 1:CAS:528:DyaK1cXhtVGgu7w%3D
5. GD, Kozloski JM, DE Vito JC, Kisicki JB, Johnson 1992; The effect of food on the absorption of methotrexate sodium tablets in healthy volunteers. Arthritis Rheum 35:761-4. 1622413 1:CAS:528:DyaK38Xlslyiu74%3D
6. M, Ahern J, Booth A, Loxton P, McCarthy P, Meffin S, Kevat 1988; Methotrexate kinetics in rheumatoid arthritis: Is there an interaction with nonsteroidal antiinflammatory drugs? J Rheumatol 15:1356-60. 3199396 1:STN:280:BiaD28fmtVU%3D
7. RA, Herman P, Veng-Pedersen J, Hoffman R, Koehnke DE, Furst 1989; Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients. J Pharm Sci 78:165-71. 2715941 1:STN:280:BiaB3sngslM%3D
8. KM, Halprin K, Fukui A, Okawara 1971; Blood levels of methotrexate and the treatment of psoriasis. Arch Dermatol 103:243-9. 10.1001/ archderm.103.3.243 5107871 1:STN:280:CS6C3sjltVE%3D
9. RA, Hamilton JM, Kremer 1995; The effect of food on methotrexate absorption. J Rheumatol 22:630-2. 7791153 1:STN:280:ByqA3M7isVw%3D
10. S, Kevat M, Ahern P, Hall 1988; Pancytopenia induced by low-dose methotrexate for rheumatoid arthritis. Aust N Z Med J 18:697-700. 1:STN:280:BiaB38josFM%3D
11. FC, Arnett SM, Edworthy DA, Bloch DJ, McShane JF, Fries NS, Cooper 1988; The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-24. 3358796 1:STN:280:BieC1M3nt1Q%3D
12. T, Hirai M, Kitamura Y, Inoue 1994; Sensitive analytical procedure for methotrexate and its main metabolite 7-hydroxymethotrexate in serum by high-performance liquid chromatography (in Japanese). Yakugaku Zasshi 114:602-10. 7932104 1:CAS:528:DyaK2MXivFKgsrs%3D A1994PE63100007
13. J, Lansbury 1968; Clinical appraisal of the activity index as a measure of rheumatoid activity. Arthritis Rheum 11:599-604. 5302852 1:STN:280:CCeH3cbps1w%3D
14. T, Pincus JA, Summey SA, Soraci Jr KA, Wallston NP, Hummon 1983; Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26:1346-53. 6639693 1:STN:280:BiuD2M3mt1Q%3D
15. O, Steinbrocker CH, Traeger RC, Batterman 1949; Therapeutic criteria in rheumatoid arthritis. JAMA 140:659-62. A1949UD23200001
16. S, Kashiwazaki Y, Ichikawa S, Sugawara I, Nagaya S, Kawai M, Hakota 1996; Determination of the clinical optimal dose of L-377 (methotrexate capsule) for the treatment of rheumatoid arthritis (in Japanese). Jpn J Inflamm 16:483-58.